ID: ALA5279818

Max Phase: Preclinical

Molecular Formula: C20H25NO2

Molecular Weight: 311.43

Associated Items:

Representations

Canonical SMILES:  COc1cc(CCN(C)C)c2c(c1OC)-c1ccccc1CC2

Standard InChI:  InChI=1S/C20H25NO2/c1-21(2)12-11-15-13-18(22-3)20(23-4)19-16-8-6-5-7-14(16)9-10-17(15)19/h5-8,13H,9-12H2,1-4H3

Standard InChI Key:  YBEFJOYLICFFIN-UHFFFAOYSA-N

Associated Targets(Human)

Dopamine D2 receptor 23596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 311.43Molecular Weight (Monoisotopic): 311.1885AlogP: 3.57#Rotatable Bonds: 5
Polar Surface Area: 21.70Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.14CX LogP: 4.10CX LogD: 2.35
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.84Np Likeness Score: 0.58

References

1. Rojas S, Parravicini O, Vettorazzi M, Tosso R, Garro A, Gutiérrez L, Andújar S, Enriz R..  (2020)  Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations.,  208  [PMID:32949964] [10.1016/j.ejmech.2020.112792]

Source